Cargando…

Cancer and Essential Hypertension

Detalles Bibliográficos
Autor principal:	Zondek, S. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1952
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007801/ https://www.ncbi.nlm.nih.gov/pubmed/14954082

Ejemplares similares

Malignant Growths (including Leukaemia) and Essential Hypertension
por: Zondek, S. G., et al.
Publicado: (1953)

THE EFFECT OF PROLONGED APPLICATION OF LARGE DOSES OF FOLLICULAR HORMONE ON THE UTERUS OF RABBITS
por: Zondek, Bernhard
Publicado: (1936)

Essential hypertension /
Publicado: (1979)

Management of essential hypertension /
por: McMahon, F. Gilbert (Francis Gilbert), 1923-
Publicado: (1978)

Tai Chi for Essential Hypertension
por: Wang, Jie, et al.
Publicado: (2013)

Rauwolfia Serpentina in Essential Hypertension
por: Chakravarty, N. K., et al.
Publicado: (1951)

Epigenetic Modifications in Essential Hypertension
por: Wise, Ingrid A., et al.
Publicado: (2016)

Epidemiology of Childhood Onset Essential Hypertension
por: Gupta-Malhotra, Monesha, et al.
Publicado: (2018)

An Evaluation of Glucose Tolerance in Essential Hypertension
por: Tugrul, Armagan, et al.
Publicado: (2009)

Fundus Autofluorescence in Chronic Essential Hypertension
por: Ramezani, Alireza, et al.
Publicado: (2014)

Comparisons of microvascular and macrovascular changes in aldosteronism-related hypertension and essential hypertension
por: Varano, Monica, et al.
Publicado: (2017)

FAILURE OF SALT TO MOBILISE RENAL DOPAMINE IN ESSENTIAL HYPERTENSION
por: Perkins, C.M., et al.
Publicado: (1980)

The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension
por: Karaca, Mustafa, et al.
Publicado: (2014)

Essential Hypertension—Evaluation of Therapeutic Results
Publicado: (1931)

The Vasoactive Mas Receptor in Essential Hypertension
por: Povlsen, Amalie L., et al.
Publicado: (2020)

Novel methylation mark and essential hypertension
por: Chaudhary, Mayank
Publicado: (2022)

Advances in pathogenesis and treatment of essential hypertension
por: Ma, Jun, et al.
Publicado: (2022)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

Prevalence and Association of Microalbuminuria in Essential Hypertensive Patients
por: Poudel, Bibek, et al.
Publicado: (2012)

Yoga for Essential Hypertension: A Systematic Review
por: Wang, Jie, et al.
Publicado: (2013)

Observation of the Serum Uric Acid in Essential Hypertension
por: Kim, Yeon Ho, et al.
Publicado: (1986)

Recent Work Concerning the Ætiology of Essential Hypertension
por: Snodgrass, W. R.
Publicado: (1938)

THE PATHOGENESIS OF ESSENTIAL HYPERTENSION: Proceedings of the Prague Symposium
Publicado: (1963)

The Impact of Vitamin D in the Treatment of Essential Hypertension
por: Legarth, Christian, et al.
Publicado: (2018)

Efficacy and Safety of Perindopril in Patients with Essential Hypertension
por: Hodzic, Enisa, et al.
Publicado: (2020)

Early Programming of Adult Systemic Essential Hypertension
por: Guarner-Lans, Verónica, et al.
Publicado: (2020)

Pharmacotherapy for Essential Hypertension: A Brief Review
por: Heidari, Behnam, et al.
Publicado: (2022)

Association Study: The Aminopeptidase a Gene and Essential Hypertension
por: Sano, Morihiko, et al.
Publicado: (2005)

Essential Hypertension and Oxidative Stress: Novel Future Perspectives
por: Franco, Caterina, et al.
Publicado: (2022)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Essential Hypertension: An Approach to Its Etiology and Neurogenic Pathophysiology
por: Bolívar, Juan J.
Publicado: (2013)

Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
por: Fowdar, Javed Y., et al.
Publicado: (2012)

The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension
por: Park, Ji-Eun, et al.
Publicado: (2017)

Beneficial effects of nonpharmacological interventions in the management of essential hypertension
por: Vamvakis, Anastasios, et al.
Publicado: (2017)

Associations between PPARG polymorphisms and the risk of essential hypertension
por: Cai, Gaojun, et al.
Publicado: (2017)

Essential hypertension in children, a growing worldwide problem
por: Sabri, Mohammadreza, et al.
Publicado: (2019)

Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension
por: Rahman, Farhana, et al.
Publicado: (2021)

Variability of diabetic macular edema in correlation with hypertension retinopathy in patients with diabetes mellitus and essential hypertension
por: Stana, Daniela, et al.
Publicado: (2019)

Continuous Oral Hexamethonium in Essential Hypertension: Further Experiences in Treatment
por: Shaw, Gavin B.
Publicado: (1952)

Treatment of Essential Hypertension does not Normalize Capillary Rarefaction
por: de Araújo Penna, Guilherme Loures, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e8i0qmvosh44arghtqionc955c